Skip to content
Search

Latest Stories

DHSC issues multiple drug supply alerts

The Department of Health and Social Care (DHSC) has issued a supply disruption notification for Azathioprine tablets and updates regarding the ongoing shortages of Sayana Press injection, Mianserin, Disopyramide, Clonidine and Synphase tablets and Seroxat oral solution.

All suppliers of Azathioprine 25mg tablets are out of stock, according to the PSNC. This may last until the w/c January 27.


Pfizer’s contraceptive injection Sayana Press (medroxyprogesterone acetate 104mg), which is out of stock since August 2019 due to manufacturing delays, is now expected to be back for resupply in the first quarter of this year. Depo-Provera (medroxyprogesterone acetate 150 mg) is currently available to support the market if clinicians consider a medicine switch appropriate.

Mylan, which issued a supply notice for Mianserin 10 mg and 30mg tablets has now extended the resupply date to June 2020. The resupply date for the manufacturer’s Disopyramide 10 mg capsules also extended to March. However, supplies of both products are available from specialist importers.

The updated resupply date for Clonidine 25mcg tablets and Synphase (Ethinylestradiol and Norethisterone) tablets are also changed respectively to mid/end February 2020 and end January 2020.

DHSC also updated the resupply date for Seroxat (paroxetine) 20mg/10ml oral solution from previously announced January 2020 to February 2020 and reminded that paroxetine tablets, which can be prescribed in place of oral solutions, are available from various suppliers.

Unlicensed preparation of paroxetine 20mg/10ml oral solution is available from importers Clinigen, WEP Clinical, Mawdsleys and Target Healthcare Ltd.

If a prescriber wishes a pharmacist to dispense an import, PSNC advises to annotate such prescriptions as ‘specials/unlicensed’ in the prescribing line and endorse as follows:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied;
  • SP

As per a memo from Specialist Pharmacy Service (SPS), the resupply date for Salofalk (mesalazine) suppositories 500mg by Dr Folk is also pushed back to mid-April 2020 with no date confirmed for the 1g suppositories.

More For You

Antibiotic prescribing for sore throats in England's pharmacies is twice as high as in Wales

Antibiotic supply rate was 72.7% under England’s Acute Sore Throat Pharmacy First compared to just 29.9% under Wales’ Sore Throat Test and Treat (STTT) scheme in six months.

Getty Images

Sore throat treatment: England pharmacies twice as likely to prescribe antibiotics as Welsh counterparts

A new study has highlighted significant differences in antibiotic use for sore throat treatment between pharmacies in England and Wales, suggesting that incorporating throat swabs to confirm bacterial infections could help reduce “unnecessary antibiotic supply.”

The study, published in the Journal of Antimicrobial Chemotherapy and first reported by The Independent, found that pharmacies in England were twice as likely to prescribe antibiotics for sore throats compared to those in Wales.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less
NPA and IPA urge NHS England to release pharmacy economic analysis immediately

Pharmacy bodies call for transparency on the funding gap amid ongoing contract negotiations.

Getty Images

Pharmacy bodies demand immediate release of economic analysis

The National Pharmacy Association (NPA) and the Independent Pharmacies Association (IPA) have jointly written to NHS England, demanding the immediate release of the independent economic analysis of pharmacy finances commissioned last autumn.

An open letter, signed by the owners of 3,034 pharmacies in England, calls for transparency on the funding gap amid ongoing contract negotiations.

Keep ReadingShow less
Discrimination: Asian and Black patients report lack of trust in primary care providers

Ethnic minority groups had worse experiences in their communication with their GP practice and felt taken less seriously

Getty Images

Survey reveals alarming rates of ethnic discrimination in NHS primary care

A recent survey by the NHS Race and Health Observatory has highlighted a worrying lack of trust in NHS primary care services among Black, Asian, and ethnic minority patients, who reported experiencing “racial or ethnic discrimination.”

Out of 2,680 survey respondents, only 55% reported trusting primary care providers to meet their health needs most or all of the time

Keep ReadingShow less